Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

JAZETA 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/JAZETA 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

JAZETA 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Zentiva K.S.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Mar 31, 2022
Approval ID: fa8fdf03595c4a85
Company: Zentiva K.S.
Type: Standard

Approval Details

Approval Id: fa8fdf03595c4a85
Drug Cima Aemps Name: JAZETA 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 86726
Holder Company Name: Zentiva K.S.
Marketing Company Name: Zentiva Spain S.L.
Holder Company Detail Path: /organization/zentiva-k-s
Authorization Date: 2022-03-31
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 50 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Zentiva K.S.
Company Detail Path: /organization/zentiva-k-s

Company Information

Pharmaceutical Company Name: Zentiva, k.s.
Country Name: Czech Republic
City Name: praha,hlavní město praha,country_cz
Address: U kabelovny 130/22

Active Ingredients

SITAGLIPTINA HIDROCLORURO

54,47 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 31, 2022

Approval ID

fa8fdf03595c4a85

Type

Standard

Back to CIMA-AEMPS Approvals